(a) Change of Location.
  (1) When a pharmacy changes location, the following is applicable:
    (A) A new completed pharmacy application containing the information outlined in §291.1 of this title (relating to Pharmacy License Application) must be filed with the board not later than 30 days before the date of the change of location of the pharmacy;
    (B) An amended license reflecting the new location of the pharmacy will be issued by the board; and
    (C) A fee as specified in §291.6 of this title (relating to Pharmacy License Fees) will be charged for processing the application for change of location.
  (2) At least 14 days prior to the change of location of a pharmacy that dispenses prescription drug orders, the pharmacist-in-charge shall post a sign in a conspicuous place indicating that the pharmacy is changing locations. Such sign shall be in the front of the prescription department and at all public entrance doors to the pharmacy and shall indicate the date the pharmacy is changing locations.
  (3) Disasters, accidents, and emergencies which require the pharmacy to change location shall be immediately reported to the board. If a pharmacy changes location suddenly due to disasters, accidents, or other emergency circumstances and the pharmacist-in-charge cannot provide notification 14 days prior to the change of location, the pharmacist-in-charge shall comply with the provisions of paragraph (2) of this subsection as far in advance of the change of location as allowed by the circumstances.
  (4) When a Class A-S, C-S, or E-S pharmacy changes location, the pharmacy's classification will revert to a Class A, Class C, or Class E unless or until the board or its designee has inspected the new location to ensure the pharmacy meets the requirements as specified in §291.133 of this title (relating to Pharmacies Compounding Sterile Preparations).
  (5) When a Class B pharmacy changes location, the board shall inspect the pharmacy at the new location to ensure the pharmacy meets the requirements as specified in subchapter C of this title (relating to Nuclear Pharmacy (Class B)) prior to the pharmacy becoming operational.
(b) Change of Name. When a pharmacy changes its name, the following is applicable:
  (1) A new completed pharmacy application containing the information outlined in §291.1 of this title (relating to Pharmacy License Application) must be filed with the board within 10 days of the change of name of the pharmacy;
  (2) An amended license reflecting the new name of the pharmacy will be issued by the board; and
  (3) A fee as specified in §291.6 of this title (relating to Pharmacy License Fees) will be charged for processing the application for change of name.
(c) Change of Managing Officers.
  (1) The owner of a pharmacy shall notify the board in writing within 10 days of a change of any managing officer of a partnership or corporation which owns a pharmacy. The written notification shall include the effective date of such change, an updated sworn disclosure statement as required by §560.052(b) of the Act and as specified in §291.4 of this title (relating to Sworn Disclosure Statement), and the following information for all managing officers:
    (A) name and title;
    (B) home address and telephone number;
    (C) date of birth;
    (D) a copy of social security card or other official document showing the social security number as approved by the board; and
    (E) a copy of current driver's license, state issued photo identification card, or passport.
  (2) For purposes of this subsection, managing officers are defined as the top four executive officers, including the corporate officer in charge of pharmacy operations, who are designated by the partnership or corporation to be jointly responsible for the legal operation of the pharmacy.
(d) Change of Ownership.
  (1) When a pharmacy changes ownership, a new pharmacy application must be filed with the board following the procedures as specified in §291.1 of this title (relating to Pharmacy License Application), including, as required by §560.052(b) of the Act, the submission of a sworn disclosure statement as specified in §291.4 of this title (relating to Sworn Disclosure Statement). In addition, a copy of the purchase contract or mutual agreement between the buyer and seller must be submitted.
  (2) A fee as specified in §291.6 of this title will be charged for issuance of a new license.
(e) Change of Pharmacist Employment.
  (1) Change of pharmacist employed in a pharmacy. When a change in pharmacist employment occurs, the pharmacist shall report such change in writing to the board within 10 days.
  (2) Change of pharmacist-in-charge of a pharmacy. The incoming pharmacist-in-charge shall be responsible for notifying the board within 10 days in writing on a form provided by the board that a change of pharmacist-in-charge has occurred. The notification shall include the following:
    (A) the name and license number of the departing pharmacist-in-charge;
    (B) the name and license number of the incoming pharmacist-in-charge;
    (C) the date the incoming pharmacist-in-charge became the pharmacist-in-charge; and
    (D) a statement signed by the incoming pharmacist-in-charge attesting that:
      (i) an inventory, as specified in §291.17 of this title (relating to Inventory Requirements), has been conducted by the departing and incoming pharmacists-in-charge; if the inventory was not taken by both pharmacists, the statement shall provide an explanation; and
      (ii) the incoming pharmacist-in-charge has read and understands the laws and rules relating to this class of pharmacy.
(f) Notification of Theft or Loss of a Controlled Substance or a Dangerous Drug.
  (1) Controlled substances. For the purposes of the Act, §562.106, the theft or significant loss of any controlled substance by a pharmacy shall be reported in writing to the board immediately on discovery of such theft or loss. A pharmacy shall be in compliance with this subsection by submitting to the board a copy of the Drug Enforcement Administration (DEA) report of theft or loss of controlled substances, DEA Form 106, or by submitting a list of all controlled substances stolen or lost.
  (2) Dangerous drugs. A pharmacy shall report in writing to the board immediately on discovery the theft or significant loss of any dangerous drug by submitting a list of the name and quantity of all dangerous drugs stolen or lost.
(g) Fire or Other Disaster. If a pharmacy experiences a fire or other disaster, the following requirements are applicable.
  (1) Responsibilities of the pharmacist-in-charge.
    (A) The pharmacist-in-charge shall be responsible for reporting the date of the fire or other disaster which may affect the strength, purity, or labeling of drugs, medications, devices, or other materials used in the diagnosis or the treatment of injury, illness, and disease; such notification shall be reported to the board, within 10 days from the date of the disaster.
    (B) The pharmacist-in-charge or designated agent shall comply with the following procedures.
      (i) If controlled substances, dangerous drugs, or Drug Enforcement Administration (DEA) order forms are lost or destroyed in the disaster, the pharmacy shall:
        (I) notify the DEA and the board of the loss of the controlled substances or order forms immediately upon discovery; and
        (II) notify the board in writing of the loss of the dangerous drugs by submitting a list of the dangerous drugs lost.
      (ii) If the extent of the loss of controlled substances or dangerous drugs is not able to be determined, the pharmacy shall:
        (I) take a new, complete inventory of all remaining drugs specified in §291.17(c) of this title (relating to Inventory Requirements);
        (II) submit to the DEA a statement attesting that the loss of controlled substances is indeterminable and that a new, complete inventory of all remaining controlled substances was conducted and state the date of such inventory; and
        (III) submit to the board a statement attesting that the loss of controlled substances and dangerous drugs is indeterminable and that a new, complete inventory of the drugs specified in §291.17(c) of this title was conducted and state the date of such inventory.
    (C) If the pharmacy changes to a new, permanent location, the pharmacist-in-charge shall comply with subsection (a) of this section.
Cont'd...
(D) If the pharmacy moves to a temporary location, the pharmacist shall comply with subsection (a) of this section. If the pharmacy returns to the original location, the pharmacist-in-charge shall again comply with subsection (a) of this section.
    (E) If the pharmacy closes due to fire or other disaster, the pharmacy may not be closed for longer than 90 days as specified in §291.11 of this title (relating to Operation of a Pharmacy).
    (F) If the pharmacy discontinues business (ceases to operate as a pharmacy), the pharmacist-in-charge shall comply with §291.5 of this title (relating to Closing a Pharmacy).
    (G) The pharmacist-in-charge shall maintain copies of all inventories, reports, or notifications required by this section for a period of two years.
  (2) Drug stock.
    (A) Any drug which has been exposed to excessive heat, smoke, or other conditions which may have caused deterioration shall not be dispensed.
    (B) Any potentially adulterated or damaged drug shall only be sold, transferred, or otherwise distributed pursuant to the provisions of the Texas Food Drug and Cosmetics Act (Chapter 431, Health and Safety Code) administered by the Bureau of Food and Drug Safety of the Texas Department of State Health Services.
(h) Notification to Consumers.
  (1) Pharmacy.
    (A) Every licensed pharmacy shall provide notification to consumers of the name, mailing address, Internet site address, and telephone number of the board for the purpose of directing complaints concerning the practice of pharmacy to the board. Such notification shall be provided as follows.
      (i) If the pharmacy serves walk-in customers, the pharmacy shall either:
        (I) post in a prominent place that is in clear public view where prescription drugs are dispensed:
          (-a-) a sign which notifies the consumer that complaints concerning the practice of pharmacy may be filed with the board and list the board's name, mailing address, Internet site address, telephone number, and a toll-free telephone number for filing complaints; or
          (-b-) an electronic messaging system in a type size no smaller than ten-point Times Roman which notifies the consumer that complaints concerning the practice of pharmacy may be filed with the board and list the board's name, mailing address, Internet site address, telephone number, and a toll-free number for filing complaints; or
        (II) provide with each dispensed prescription a written notification in a type size no smaller than ten-point Times Roman which states the following: "Complaints concerning the practice of pharmacy may be filed with the Texas State Board of Pharmacy at: (list the mailing address, Internet site address, telephone number of the board, and a toll-free telephone number for filing complaints)."
      (ii) If the prescription drug order is delivered to patients at their residence or other designated location, the pharmacy shall provide with each dispensed prescription a written notification in type size no smaller than ten-point Times Roman which states the following: "Complaints concerning the practice of pharmacy may be filed with the Texas State Board of Pharmacy at: (list the mailing address, Internet site address, telephone number, and a toll-free telephone number for filing complaints)." If multiple prescriptions are delivered to the same location, only one such notice shall be required.
      (iii) The provisions of this subsection do not apply to prescriptions for patients in facilities where drugs are administered to patients by a person required to do so by the laws of the state (i.e., nursing homes).
    (B) A pharmacy that maintains a generally accessible site on the Internet that is located in Texas or sells or distributes drugs through this site to residents of this state shall post the following information on the pharmacy's initial home page and on the page where a sale of prescription drugs occurs.
      (i) Information on the ownership of the pharmacy, to include at a minimum, the:
        (I) owner's name or if the owner is a partnership or corporation, the partnership's or corporation's name and the name of the chief operating officer;
        (II) owner's address;
        (III) owner's telephone number; and
        (IV) year the owner began operating pharmacies in the United States.
      (ii) The Internet address and toll free telephone number that a consumer may use to:
        (I) report medication/device problems to the pharmacy; and
        (II) report business compliance problems.
      (iii) Information about each pharmacy that dispenses prescriptions for this site, to include at a minimum, the:
        (I) pharmacy's name, address, and telephone number;
        (II) name of the pharmacist responsible for operation of the pharmacy;
        (III) Texas pharmacy license number for the pharmacy and a link to the Internet site maintained by the Texas State Board of Pharmacy; and
        (IV) the names of all other states in which the pharmacy is licensed, the license number in that state, and a link to the Internet site of the entity that regulates pharmacies in that state, if available.
    (C) A pharmacy whose Internet site has been verified by the National Association of Boards of Pharmacy to be in compliance with the laws of this state, as well as in all other states in which the pharmacy is licensed shall be in compliance with subparagraph (B) of this paragraph.
  (2) Texas State Board of Pharmacy. On or before January 1, 2005, the board shall establish a pharmacy profile system as specified in §2054.2606, Government Code.
    (A) The board shall make the pharmacy profiles available to the public on the agency's Internet site.
    (B) A pharmacy profile shall contain at least the following information:
      (i) name, address, and telephone number of the pharmacy;
      (ii) pharmacy license number, licensure status, and expiration date of the license;
      (iii) the class and type of the pharmacy;
      (iv) ownership information for the pharmacy;
      (v) names and license numbers of all pharmacists working at the pharmacy;
      (vi) whether the pharmacy has had prior disciplinary action by the board;
      (vii) whether the pharmacy's consumer service areas are accessible to disabled persons, as defined by law;
      (viii) the type of language translating services, including translating services for persons with impairment of hearing, that the pharmacy provides for consumers; and
      (ix) insurance information including whether the pharmacy participates in the state Medicaid program.
    (C) The board shall gather this information on initial licensing and update the information in conjunction with the license renewal for the pharmacy.
(i) Notification of Licensees or Registrants Obtaining Controlled Substances or Dangerous Drugs by Forged Prescriptions. If a licensee or registrant obtains controlled substances or dangerous drugs from a pharmacy by means of a forged prescription, the pharmacy shall report in writing to the board immediately on discovery of such forgery. A pharmacy shall be in compliance with this subsection by submitting to the board the following:
  (1) name of licensee or registrant obtaining controlled substances or dangerous drugs by forged prescription;
  (2) date(s) of forged prescription(s);
  (3) name(s) and amount(s) of drug(s); and
  (4) copies of forged prescriptions.
(j) Notification of Disciplinary Action. For the purpose of the Act, §562.106, a pharmacy shall report in writing to the board not later than the 10th day after the date of:
  (1) a final order against the pharmacy license holder by the regulatory or licensing agency of the state in which the pharmacy is located if the pharmacy is located in another state; or
  (2) a final order against a pharmacist who is designated as the pharmacist-in-charge of the pharmacy by the regulatory or licensing agency of the state in which the pharmacy is located if the pharmacy is located in another state.
(k) Temporary Closing for Loss of Pharmacist-in-Charge. A pharmacy that temporarily closes for loss of a pharmacist-in-charge as provided by §291.5(d)(2) of this title shall notify the board in writing on a form provided by the board. The pharmacy shall submit the notification not later than the next business day after the date of departure of the pharmacist-in-charge.

Source Note: The provisions of this §291.3 adopted to be effective September 18, 2007, 32 TexReg 6318; amended to be effective June 7, 2009, 34 TexReg 3390; amended to be effective March 10, 2011, 36 TexReg 1511; amended to be effective June 7, 2012, 37 TexReg 4046; amended to be effective March 15, 2015, 40 TexReg 1086; amended to be effective December 6, 2015, 40 TexReg 8765; amended to be effective June 11, 2017, 42 TexReg 2931; amended to be effective January 4, 2018, 42 TexReg 7691; amended to be effective September 16, 2018, 43 TexReg 5779; amended to be effective March 5, 2020, 45 TexReg 1423; amended to b e effective December 4, 2023, 48 TexReg 7047